KRT18 and cancer: The authors also elaborated an immunofluorescence-based assay using a cocktail of monoclonal antibodies targeting cytokeratin (CK) 8 and cytokeratin 18 to specifically identify cancer cells, since both CK8/CK18 are nearly present in all tumors of epithelial origin.